G. Walmsley Graham, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 1,175,000 shares at $14.85 ($17.4M) on 2024-06-04, disclosed to the SEC on 2024-06-06.
Open-market sale of $17.4M OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.85 | 475,000 | $7.1M | 40.4% |
| 2 | $14.85 | 700,000 | $10.4M | 59.6% |
| Total | $14.85 avg | 1,175,000 | $17.4M | 100% |
| Filing → |
| OLMA | BUY | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | SELL | 2024-12-18 | $9.5M | — | Filing → |
| OLMA | BUY | 2024-12-17 | $4.7M | — | Filing → |